AmCham China president says pharma companies have reported tariff exemptions on China imports
BEIJING, April 25 (Reuters) - American Chamber of Commerce in China President Michael Hart said companies in the pharmaceutical sector had reported that they had been able to import drugs to China in the past week with tariff exemptions.
He said he believed that the exemptions granted by China were drug-specific, not industry wide in nature.
Reuters had previously quoted Hart as saying that some companies had reported some goods were being granted tariff exemptions without specifying that the reports were from pharmaceutical companies.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Vanguard ETF Could Beat the S&P 500 Again in 2026 —— Why Investors Are Paying Attention

Meta Stock Price Forecast 2026-2030: Can META Hit $1,000?

Tradingkey







